Thiard News@F4F

@newsen.bsky.social

1 day ago

Top 13 Important Press Releases You Shouldn't Miss This Week Discover the most significant press releases from the past week that impact various industries, including healthcare and technology.

Top 13 Important Press Releases You Shouldn't Miss This Week #United_States #New_York #FDA_Approval #United_Airlines #KitchenAid

Thiard News@F4F

@newsen.bsky.social

4 days ago

Lupin Limited Secures FDA Tentative Approval for Sugammadex Injection Lupin Limited has achieved tentative approval from the U.S. FDA for Sugammadex Injection, marking a significant step in enhancing surgical care in the U.S.

Lupin Limited Secures FDA Tentative Approval for Sugammadex Injection #India #FDA_Approval #Mumbai #Lupin #Sugammadex

Thiard News@F4F

@newsen.bsky.social

5 days ago

Haemonetics' VASCADE MVP® XL System Gains FDA Approval for Expanded Use Haemonetics Corporation receives FDA approval to expand the VASCADE MVP® XL system's use for advanced vascular closure procedures, enhancing patient care.

Haemonetics' VASCADE MVP® XL System Gains FDA Approval for Expanded Use #USA #FDA_Approval #Boston #Haemonetics #VASCADE_MVP

Thiard News@F4F

@newsen.bsky.social

1 week ago

Wingderm®'s Lasermach Achieves FDA Clearance for All Wavelengths Wingderm® has received expanded FDA clearance for its Lasermach system, now authorized for all three wavelengths, enhancing hair removal capabilities.

Wingderm®'s Lasermach Achieves FDA Clearance for All Wavelengths #USA #FDA_Approval #Denver #Wingderm #Lasermach

Thiard News@F4F

@newsen.bsky.social

1 week ago

Hansa Biopharma Unveils Transformative Achievements in Its 2025 Annual and Sustainability Reports Hansa Biopharma's 2025 Annual and Sustainability Reports celebrate a year of substantial growth and scientific advancements, reflecting strong progress in healthcare.

Hansa Biopharma Unveils Transformative Achievements in Its 2025 Annual and Sustainability Reports #Sweden #FDA_Approval #Lund #Hansa_Biopharma #imlifidase

Thiard News@F4F

@newsen.bsky.social

1 week ago

Implantica's Year-End Report Highlights Progress Towards RefluxStop Launch in the US Implantica shares significant milestones in its Year-End Report, focusing on the upcoming US launch of RefluxStop, pending FDA approval.

Implantica's Year-End Report Highlights Progress Towards RefluxStop Launch in the US #FDA_Approval #Liechtenstein #Vaduz #Implantica #RefluxStop

Thiard News@F4F

@newsen.bsky.social

2 weeks ago

Investors Allege Fraud in Soleno Therapeutics Clinical Trials, Seek Class Action Status A pending class action lawsuit against Soleno Therapeutics, Inc. claims that the company's clinical trials for a key drug were flawed. Investors may pursue compensation for their losses.

Investors Allege Fraud in Soleno Therapeutics Clinical Trials, Seek Class Action Status #USA #New_York #FDA_Approval #VYKAT_XR #Soleno_Therapeutics

Thiard News@F4F

@newsen.bsky.social

3 weeks ago

Baird Medical's Regulatory Approval in Argentina Marks a New Era for Global Expansion Baird Medical gains regulatory clearance in Argentina to enhance global reach. This approval supports their mission of expanding access to innovative therapies worldwide.

Baird Medical's Regulatory Approval in Argentina Marks a New Era for Global Expansion #FDA_Approval #Argentina #Buenos_Aires #Baird_Medical #microwave_ablation

Thiard News@F4F

@newsen.bsky.social

3 weeks ago

Pierre Fabre Pharmaceuticals Advances Regulatory Discussion with FDA on Tabelecleucel for Critical Cancer Treatment Pierre Fabre Pharmaceuticals is moving forward with a Type A meeting with the FDA regarding the biologic license application for Tabelecleucel, aimed at treating relapsed EBV-positive PTLD.

Pierre Fabre Pharmaceuticals Advances Regulatory Discussion with FDA on Tabelecleucel for Critical Cancer Treatment #USA #FDA_Approval #Tabelecleucel #Pierre_Fabre #Secaucus,_NJ

Thiard News@F4F

@newsen.bsky.social

4 weeks ago

Revolutionary LifeVac: FDA Grants Approval for Unique Anti-Choking Device LifeVac, an innovative anti-choking device, is now the first device of its kind authorized by the FDA, offering crucial support during emergencies.

Revolutionary LifeVac: FDA Grants Approval for Unique Anti-Choking Device #USA #FDA_Approval #LifeVac #Nesconset #Anti-Choking

Thiard News@F4F

@newsen.bsky.social

4 weeks ago

GNTbm-38 Receives FDA IND Approval for Phase I Clinical Trials, Promising New Hope in Cancer Immunotherapy GNTbm-38, an innovative anticancer drug, has gained IND approval from the FDA, paving the way for Phase I clinical trials in the U.S. Its development signals a significant advancement in cancer immunotherapy.

GNTbm-38 Receives FDA IND Approval for Phase I Clinical Trials, Promising New Hope in Cancer Immunotherapy #Taipei #USA #FDA_Approval #Cancer_Immunotherapy #GNTbm-38

Thiard News@F4F

@newsen.bsky.social

1 month ago

Hansa Biopharma's Imlifidase BLA Receives PDUFA Date of December 2026 Hansa Biopharma announces the PDUFA action date for imlifidase, set for December 19, 2026, signaling progress for kidney transplant options.

Hansa Biopharma's Imlifidase BLA Receives PDUFA Date of December 2026 #Sweden #FDA_Approval #Lund #Hansa_Biopharma #imlifidase

Thiard News@F4F

@newsen.bsky.social

1 month ago

INO Shares Plunge 24% Following FDA Review Setback Announcement by Inovio Pharmaceuticals Inovio Pharmaceuticals experiences a 24% drop in share value as a recent FDA announcement casts a shadow on its regulatory approval prospects.

INO Shares Plunge 24% Following FDA Review Setback Announcement by Inovio Pharmaceuticals #USA #New_York #FDA_Approval #Stock_Market #INOVIO_Pharmaceuticals

Thiard News@F4F

@newsen.bsky.social

1 month ago

Glenmark Specialty SA Secures FDA Approval for Fluticasone Propionate Inhalation Aerosol with Exclusivity Glenmark Specialty SA has received FDA approval for its Fluticasone Propionate Inhalation Aerosol, marking a significant milestone with 180 days of generic therapy exclusivity.

Glenmark Specialty SA Secures FDA Approval for Fluticasone Propionate Inhalation Aerosol with Exclusivity #United_States #FDA_Approval #Glenmark_Pharmaceuticals #Fluticasone_Propionate #Elmwood_Park,_NJ

Thiard News@F4F

@newsen.bsky.social

1 month ago

Revolutionizing Breast Cancer Surgery: Claire Becomes First AI Device Approved by FDA Perimeter Medical Imaging's Claire has gained FDA approval, transforming breast cancer surgery with real-time AI imaging technology to reduce repeat surgeries.

Revolutionizing Breast Cancer Surgery: Claire Becomes First AI Device Approved by FDA #USA #Dallas #FDA_Approval #Perimeter_Medical_AI #CLAIRE

Thiard News@F4F

@newsen.bsky.social

1 month ago

Significant Regulatory Milestone: Vanda's HETLIOZ® Hearing on Jet Lag Disorder Approved by the FDA Vanda Pharmaceuticals achieves a groundbreaking approval from the FDA for a hearing on HETLIOZ® concerning jet lag disorder, a significant step in drug regulation.

Significant Regulatory Milestone: Vanda's HETLIOZ® Hearing on Jet Lag Disorder Approved by the FDA #United_States #FDA_Approval #Washington #Vanda_Pharmaceuticals #HETLIOZ®

Thiard News@F4F

@newsen.bsky.social

1 month ago

SciBase's FDA Approval Allows Expanded Nevisense Usage for Healthcare Professionals SciBase receives FDA approval to extend Nevisense labelling, enabling healthcare practitioners beyond dermatologists to perform crucial skin assessments.

SciBase's FDA Approval Allows Expanded Nevisense Usage for Healthcare Professionals #Sweden #FDA_Approval #Stockholm #Nevisense #SciBase

Thiard News@F4F

@newsen.bsky.social

1 month ago

Alarming Stock Drop of Corcept Therapeutics Sparks Class Action Lawsuit Due to FDA Approval Issues Corcept Therapeutics faces a class action lawsuit following a significant stock drop fueled by FDA approval issues. Investors are urged to respond promptly.

Alarming Stock Drop of Corcept Therapeutics Sparks Class Action Lawsuit Due to FDA Approval Issues #USA #Class_Action #FDA_Approval #New_Orleans #Corcept_Therapeutics

Thiard News@F4F

@newsen.bsky.social

1 month ago

uniQure N.V. Faces Class Action as FDA Approval Delayed and Stock Drops 49% Investors are alerted to a class action lawsuit against uniQure N.V., following a significant stock decline due to FDA approval delays.

uniQure N.V. Faces Class Action as FDA Approval Delayed and Stock Drops 49% #United_States #New_York #FDA_Approval #Securities_Fraud #uniQure_N.V.

Thiard News@F4F

@newsen.bsky.social

1 month ago

Lupin Limited Announces FDA Approval and U.S. Launch of Brivaracetam Oral Solution for Seizures Lupin Limited has received FDA approval for Brivaracetam Oral Solution, a treatment for seizures, and is now launching it in the U.S. market.

Lupin Limited Announces FDA Approval and U.S. Launch of Brivaracetam Oral Solution for Seizures #United_States #FDA_Approval #Naples #Lupin_Limited #Brivaracetam

Thiard News@F4F

@newsen.bsky.social

1 month ago

Xenocor's Saberscope® Receives FDA Approval for Enhanced Surgical Visualization Xenocor's new Saberscope®, a single-use 5mm laparoscope, gains FDA approval, transforming surgical visualization with improved safety and efficiency.

Xenocor's Saberscope® Receives FDA Approval for Enhanced Surgical Visualization #FDA_Approval #Xenocor #Saberscope

Thiard News@F4F

@newsen.bsky.social

1 month ago

Armata Pharmaceuticals Achieves FDA QIDP Status for New Bacteriophage Therapeutic Armata Pharmaceuticals has announced FDA QIDP designation for its innovative bacteriophage therapy AP-SA02, aimed at treating severe Staphylococcus aureus infections, highlighting its commitment to tackling antibiotic resistance.

Armata Pharmaceuticals Achieves FDA QIDP Status for New Bacteriophage Therapeutic #USA #Los_Angeles #FDA_Approval #Armata_Pharmaceuticals #AP-SA02

Thiard News@F4F

@newsen.bsky.social

1 month ago

Sibel Health's FDA Acceptance Marks a Milestone in Cough Monitoring Innovations Sibel Health receives FDA acceptance for its Aria cough monitoring sensor, advancing chronic cough management technology significantly.

Sibel Health's FDA Acceptance Marks a Milestone in Cough Monitoring Innovations #USA #Chicago #FDA_Approval #Sibel_Health #Aria_Sensor

Thiard News@F4F

@newsen.bsky.social

1 month ago

FDA Approves IST's ONE TRAY® for Extended 365-Day Storage for Surgical Use Innovative Sterilization Technologies' ONE TRAY® sterilization container has received FDA clearance for a 365-day storage period, enhancing surgical efficiency.

FDA Approves IST's ONE TRAY® for Extended 365-Day Storage for Surgical Use #USA #FDA_Approval #Dayton #One_Tray #Innovative_Sterilization_Technologies

Thiard News@F4F

@newsen.bsky.social

1 month ago

Hansa Biopharma's FDA Acceptance for Innovative Imlifidase Marks a Milestone in Kidney Transplant Treatments Hansa Biopharma's biologics license application for Imlifidase has been accepted by the FDA, opening new avenues for kidney transplantation.

Hansa Biopharma's FDA Acceptance for Innovative Imlifidase Marks a Milestone in Kidney Transplant Treatments #Sweden #FDA_Approval #Lund #Hansa_Biopharma #imlifidase

Thiard News@F4F

@newsen.bsky.social

1 month ago

Hansa Biopharma's Innovative Imlifidase Receives FDA Acceptance for BLA Hansa Biopharma's biologics license application for imlifidase has been accepted by the FDA, marking a significant step for kidney transplantation treatments.

Hansa Biopharma's Innovative Imlifidase Receives FDA Acceptance for BLA #USA #FDA_Approval #Lund #Hansa_Biopharma #imlifidase

Thiard News@F4F

@newsen.bsky.social

1 month ago

uniQure N.V. Faces Securities Fraud Class Action Following FDA Approval Setbacks and Significant Stock Plunge Discover the ongoing class action lawsuit against uniQure N.V. after the company faced FDA approval delays causing its stock to drop by 49%.

uniQure N.V. Faces Securities Fraud Class Action Following FDA Approval Setbacks and Significant Stock Plunge #United_States #New_York #FDA_Approval #Securities_Fraud #uniQure

Thiard News@F4F

@newsen.bsky.social

1 month ago

KBroVet® Receives FDA Full Approval for Seizure Control in Dogs with Epilepsy KBroVet®, a potassium bromide formulation, becomes the first FDA fully approved treatment for dogs suffering from seizures related to idiopathic epilepsy, marking a significant veterinary milestone.

KBroVet® Receives FDA Full Approval for Seizure Control in Dogs with Epilepsy #United_States #FDA_Approval #Pensacola #KBroVet #Potassium_Bromide

Thiard News@F4F

@newsen.bsky.social

1 month ago

FDA Approves Phase 2 Trial for Promising New Drug AK3280 to Treat Pulmonary Fibrosis Shanghai Ark Biopharmaceutical's AK3280 has received FDA approval for Phase 2 trials, promising new hope for idiopathic pulmonary fibrosis patients. Explore the potential impact.

FDA Approves Phase 2 Trial for Promising New Drug AK3280 to Treat Pulmonary Fibrosis #Shanghai #United_States #FDA_Approval #AK3280 #Ark_Biopharmaceutical

Thiard News@F4F

@newsen.bsky.social

1 month ago

Hansa Biopharma Reports Impressive Financial Performance for Q4 and Full Year 2025 Hansa Biopharma AB announced strong financial results for both Q4 2025 and the entire year. With revenue growth and successful product milestones, the company looks ahead to future developments in kidney transplantation.

Hansa Biopharma Reports Impressive Financial Performance for Q4 and Full Year 2025 #Sweden #FDA_Approval #Lund #Hansa_Biopharma #IDEFIRIX